Correlation Between Blueprint Medicines and Taxus Cardium
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Taxus Cardium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Taxus Cardium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Taxus Cardium Pharmaceuticals, you can compare the effects of market volatilities on Blueprint Medicines and Taxus Cardium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Taxus Cardium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Taxus Cardium.
Diversification Opportunities for Blueprint Medicines and Taxus Cardium
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Blueprint and Taxus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Taxus Cardium Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taxus Cardium Pharma and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Taxus Cardium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taxus Cardium Pharma has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Taxus Cardium go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Taxus Cardium
If you would invest 9,460 in Blueprint Medicines Corp on September 20, 2024 and sell it today you would earn a total of 188.00 from holding Blueprint Medicines Corp or generate 1.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Taxus Cardium Pharmaceuticals
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Taxus Cardium Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Blueprint Medicines and Taxus Cardium Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Taxus Cardium
The main advantage of trading using opposite Blueprint Medicines and Taxus Cardium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Taxus Cardium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taxus Cardium will offset losses from the drop in Taxus Cardium's long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Taxus Cardium vs. Revolution Medicines | Taxus Cardium vs. Blueprint Medicines Corp | Taxus Cardium vs. Sana Biotechnology | Taxus Cardium vs. Kymera Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |